[Organic catatonic disorder].
Odawara
Toshinari
T
Psychiatric Center, Yokohama City University Medical Center.
D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use; D002389:Catatonia / Q000175:diagnosis / Q000209:etiology / Q000523:psychology / Q000628:therapy; D018491:Dopamine Agonists / Q000627:therapeutic use; D018492:Dopamine Antagonists / Q000627:therapeutic use; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D008590:Meningoencephalitis / Q000150:complications / Q000821:virology; D011618:Psychotic Disorders / Q000150:complications; D018967:Risperidone / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D018491:Dopamine Agonists; D018492:Dopamine Antagonists; D001569:Benzodiazepines; D001971:Bromocriptine; D018967:Risperidone